Jonathan Bayldon Baell

This inventor holds 29 USPTO granted patents and 2 published patent applications, plus 6 CIPO patents and 8 EPO patents, primarily in Anxiolytic Compounds. Top assignees: Bionomics Inc., Walter and Eliza Hall Institute of Medical Research, Genentech, Inc.. Active years: 2002-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jonathan Bayldon Baell. Retrieved from https://idiyas.com/inventor/jonathan-bayldon-baell

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 29 (Patent Applications = 2)

% Patents Active = 55.2

CIPO Patents = 6

EPO Patents = 8 (Patent Applications = 9)

Average Co-Inventor Count = 6.0

ph-index = 7

Forward Citations = 200(Granted Patents)

Location History:

Bundoora, AU (2012 - 2015)
Ivanhoe, AU (2002 - 2021)
Parkville, AU (2009 - 2021)

Company Filing History:

Walter and Eliza Hall Institute of Medical Research

Abbott Laboratories Corporation

Beijing University of Technology

patents

8. 2 out of 2

Perenna Pharmaceuticals, Inc.

patents

9. 1 out of 8

Baker Heart and Diabetes Institute

patents

10. 1 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 2002-2026

Loading Chart...

Areas of Expertise:

Anxiolytic Compounds

Potassium Channel Blockers

Protein Kinase Inhibitors

Therapeutic Agents

Fc Receptor Modulators

Benzofuran Compounds

Alpha-Helical Mimetics

Heterocyclic Compounds

Small-Molecules

Aryl Sulfonohydrazides

Chromene Compounds

Arylsulfonamide Compounds

29 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12630541 - Compounds useful as inhibitors of ALCAT 1 (2026-05-19),

2. 11208404 - Compounds useful as inhibitors of ALCAT 1 (2021-12-28),

3. 10954231 - Anxiolytic compounds (2021-03-23),

4. 10829446 - Aryl sulfonohydrazides (2020-11-10),

5. 10328075 - Method of treatment and compounds for use therein (2019-06-25),

6. 10233181 - Anxiolytic compounds (2019-03-19),

7. 9975892 - Anxiolytic compounds (2018-05-22),

8. 9573945 - Anxiolytic compounds (2017-02-21),

9. 9067928 - Compounds and methods of use (2015-06-30),

10. 9023848 - Small-molecules as therapeutics (2015-05-05),

11. 8962830 - Protein kinase inhibitors and methods of treatment (2015-02-24),

12. 8906912 - Anxiolytic compounds (2014-12-09),

13. 8614212 - Anxiolytic compounds (2013-12-24),

14. 8551990 - Anxiolytic compounds (2013-10-08),

15. 8518970 - Compounds and methods of use (2013-08-27),

Title: Jonathan Bayldon Baell - Inventor from Ivanhoe, AU

Introduction: Jonathan Bayldon Baell is a renowned inventor based in Ivanhoe, Australia, known for his groundbreaking contributions to the field of pharmaceuticals and drug discovery.

Latest Patents: Baell holds several patents in the pharmaceutical industry, with his latest inventions focusing on novel drug compounds for the treatment of various diseases.

Career Highlights: With a distinguished career spanning over two decades, Baell has worked with leading research institutions and pharmaceutical companies to develop innovative solutions for complex medical challenges. His expertise in medicinal chemistry has led to the successful development of several life-saving medications.

Collaborations: Baell has collaborated with top scientists, researchers, and pharmaceutical experts from around the world to advance the field of drug discovery. His collaborative efforts have resulted in significant advancements in the development of new therapies for critical illnesses.

Conclusion: Jonathan Bayldon Baell's dedication to innovation and his passion for improving global healthcare have solidified his reputation as a pioneering inventor in the pharmaceutical industry. His contributions continue to have a profound impact on the lives of many, making him a key figure in the world of drug discovery.

Profile summary based on public USPTO records.